1978
DOI: 10.1007/bf00507036
|View full text |Cite
|
Sign up to set email alerts
|

Opiate agonist action of antidiarrheal agents in vitro and in vivo?Findings in support for selective action

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
23
1

Year Published

1982
1982
2013
2013

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 85 publications
(25 citation statements)
references
References 16 publications
1
23
1
Order By: Relevance
“…Loperamide does not produce opiate-like discriminative stimulus effect in rats (Colpaert et al 1975) or subjective effects in humans (Jaffe et al 1980). This lack of CNS effects is presumed to result from pharmacokinetic limitations of loperamide to cross the blood-brain barrier (Wuster and Herz 1978;Niemegeers et al 1979;Yanagita et al 1980).…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…Loperamide does not produce opiate-like discriminative stimulus effect in rats (Colpaert et al 1975) or subjective effects in humans (Jaffe et al 1980). This lack of CNS effects is presumed to result from pharmacokinetic limitations of loperamide to cross the blood-brain barrier (Wuster and Herz 1978;Niemegeers et al 1979;Yanagita et al 1980).…”
Section: Discussionmentioning
confidence: 98%
“…Evidence that the peripheral effects of loperamide are similar to those of heroin (at these doses) comes from several sources. Loperamide binds to both central and peripheral opioid receptors (Wuster and Herz 1978) and exhibits an opioid-like profile in tissue bioassays (e.g. guinea pig ileum and mouse vas deferens; Gliagnoni et al 1983), antidiarrheal tests (Awouters et al 1993) and antinociceptive tests (Takasuna et al 1994).…”
Section: Discussionmentioning
confidence: 98%
“…The C max of loperamide in healthy volunteers following a single 16-mg dose has been reported as 7.8 to 8.6 nM (Doser et al, 1995;Tayrouz et al, 2001). However, loperamide is also a potent P-glycoprotein substrate (Wandel et al, 2002), and studies in laboratory animals have shown that it accumulates in the small intestine (Wuster and Herz, 1978;Lavrijsen et al, 1995). Therefore, CES2 in the intestinal epithelium may be exposed to a higher and potentially inhibitory concentration of loperamide.…”
Section: Discussionmentioning
confidence: 99%
“…The carboxylic acid metabolite is somewhat more potent than the parent drug (as assessed using a rat brain homogenate binding assay), and systemic concentrations of the metabolite are greater than for the parent (Karim et al, 1972). The target of action is the gut, so it cannot be necessarily stated that the metabolite bears the greater role in activity since the effect could be due to local exposures to parent drug upon oral administration (Wüster and Herz, 1978). In a comparison, dosing the metabolite directly to humans showed that five-times less was needed to achieve a constipatory effect the same as the parent ester (Rubens et al, 1972).…”
Section: A Drugs With Active Metabolites That Dominate the Activitymentioning
confidence: 99%